Syros Pharmaceuticals Appoints David A. Roth, M.D., As Chief Medical Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals today announced that David A. Roth, M.D., an industry leader in oncology and hematology drug development, joined the Company as its first Chief Medical Officer. Dr. Roth will provide strategic and operational leadership for all the Company’s clinical development activities and functions.